Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nutr Hosp ; 40(2): 250-256, 2023 Apr 20.
Artigo em Inglês | MEDLINE | ID: mdl-36880718

RESUMO

Introduction: Objective: the aim of this study was to compare the incidence rate of feeding intolerance (FI) during supine (SP) or prone positioning (PP) in critically ill COVID-19 patients. Methods: this was a retrospective cohort study of critically ill patients with overweight or obesity who received enteral nutrition (EN) in prone or supine positioning continuously during the first five days of mechanical ventilation. Nutritional risk, anthropometric measurements and body composition were assessed at the first 24 hours upon Intensive Care Unit (ICU) admission. Biochemical and clinical variables (Sequential Organ Failure Assessment [SOFA], Acute Physiology and Chronic Health Evaluation II [APACHE II], Acute Kidney Injury [AKI] or comorbidities diagnosis) were collected. Pharmacotherapy (prokinetics, sedatives or neuromuscular blocking agents) and FI incidence (gastric residual volume [GRV] ≥ 200 ml or ≥ 500 ml, vomiting or diarrhea) were daily recorded. Constipation was defined as the absence of evacuation for five consecutive days. Results: eighty-two patients were included. Higher rate of prophylactic prokinetic prescription was observed in PP (42.8 vs 12.5 %, p = 0.002). GRV ≥ 200 in supine position was not different when compared to PP (p = 0.47). Vomiting episodes in supine compared to PP showed no difference between groups (15 % vs 24 %, p = 0.31). No differences in diarrhea events were detected (10 % vs 4.7 %, p = 0.36). Constipation was common in both groups (95 % vs 82 %, p = 0.06). Conclusion: FI during prone position was not different in comparison to supine position. Routinely use of prokinetics in continuous prone position may help to prevent FI incidence. Algorithm development is necessary for FI prevention and treatment so to avoid EN interruptions and adverse clinical outcomes.


Introducción: Objetivo: comparar la incidencia de intolerancia a la alimentación entre pacientes críticos en posición supino (PS) o prono (PP). Métodos: cohorte retrospectiva de pacientes bajo ventilación mecánica por distrés respiratorio por COVID-19 y sobrepeso y obesidad, quienes recibieron nutrición enteral (NE) en PP o PS. Se evaluaron riesgo nutricional, mediciones antropométricas y composición corporal en las primeras 24 horas de ingreso a la Unidad de Cuidados Intensivos (UCI). Se recolectaron variables bioquímicas y clínicas (Sequential Organ Failure Assessment [SOFA], Acute Physiology and Chronic Health Evaluation II [APACHE II], lesión renal aguda y otras comorbilidades). Se registró el esquema de farmacoterapia prescrita durante los primeros cinco días (procinéticos, sedantes y bloqueadores neuromusculares). Se evaluó la incidencia de intolerancia a la alimentación, definida como la presencia de residuo gástrico (RG) ≥ 200 o ≥ 500 ml, vómito, diarrea o estreñimiento. Resultados: fueron incluidos 82 pacientes. Se observó una mayor prescripción de procinéticos como terapia profiláctica en PP (42,8 vs. 12,5 %, p = 0,002). No se observaron diferencias en RG ≥ 200 ml (p = 0,47) ni vómito (p = 0,31) entre ambos grupos. No se observaron diferencias en episodios de diarrea (10 % en PS vs. 4,7 % en PP, p = 0,36). El estreñimiento fue común en ambos grupos de estudio (95 vs. 82 %, p = 0,06). Conclusiones: la PP no se relaciona con una mayor incidencia de intolerancias a la alimentación. El uso rutinario de procinéticos durante la PP continua puede ayudar a prevenir la incidencia de dichas intolerancias. Es necesario el desarrollo de algoritmos para la prevención y tratamiento de las intolerancias a la alimentación para evitar interrupciones en la NE y desenlaces no deseables.


Assuntos
COVID-19 , Sobrepeso , Humanos , Recém-Nascido , Sobrepeso/complicações , Sobrepeso/epidemiologia , Sobrepeso/terapia , Estudos Retrospectivos , Estado Terminal/terapia , COVID-19/terapia , COVID-19/complicações , Vômito/etiologia , Unidades de Terapia Intensiva , Obesidade/complicações , Obesidade/epidemiologia , Obesidade/terapia , Diarreia/complicações , Constipação Intestinal
2.
J Nephrol ; 35(9): 2373-2375, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-35857238

RESUMO

Kidney disease in diabetes mellitus is usually explained by diabetic kidney disease, but other superimposed etiologies occur frequently. The distinction between diabetic kidney disease and non-diabetic kidney disease can only be made by performing kidney biopsy. Our objective was to evaluate the association of diabetic kidney disease, non-diabetic kidney disease, or both with renal replacement therapy initiation. This is a retrospective cohort that included patients with type 2 diabetes mellitus for whom a kidney biopsy was indicated. Subjects were followed-up for 5 years, until renal replacement therapy initiation or were lost to follow up. One hundred and forty-one patients were included, 53 (39%) had diabetic kidney disease, 13 (9%) had non-diabetic kidney disease and 75 (54%) had both. Ninety-four percent of the cohort initiated renal replacement therapy during the 5-year follow-up. Higher degree of fibrosis was associated with a trend towards higher risk of requiring renal replacement therapy. In addition, the combined diabetic kidney disease + non-diabetic kidney disease group was associated with higher need of renal replacement therapy initiation when compared to the diabetic kidney disease group.


Assuntos
Diabetes Mellitus Tipo 2 , Nefropatias Diabéticas , Insuficiência Renal Crônica , Humanos , Estudos Retrospectivos , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/epidemiologia , Fatores de Risco , Rim , Terapia de Substituição Renal/efeitos adversos , Nefropatias Diabéticas/diagnóstico , Nefropatias Diabéticas/epidemiologia , Nefropatias Diabéticas/terapia , Insuficiência Renal Crônica/complicações , Insuficiência Renal Crônica/diagnóstico , Insuficiência Renal Crônica/epidemiologia , Biópsia , Taxa de Filtração Glomerular
3.
J Infect Dev Ctries ; 15(3): 310-319, 2021 03 31.
Artigo em Inglês | MEDLINE | ID: mdl-33839703

RESUMO

Mycobacterium tuberculosis (M.tb) is the causative agent of tuberculosis (TB), an infectious disease that leads to numerous deaths worldwide. Malnutrition, smoking, alcohol abuse, Human Immunodeficiency Virus infection, and diabetes are some of the most important risk factors associated with TB development. At present, it is necessary to conduct studies on risk factors to establish new effective strategies and combat this disease. Malnutrition has been established as a risk factor since several years ago; although there is in vitro experimental evidence that reveals the importance of micronutrients in activating the immune response against M.tb, evidence from clinical trials is controversial. Currently, nutritional assessment is recommended in all TB patients upon diagnosis. However, there is insufficient evidence to indicate micronutrient supplementation as adjuvant therapy or prophylactic to prevent micronutrient depletion. Strengthening the interaction between basic and clinical research is necessary to carry out studies that will help establish adjuvant therapies to improve outcomes in TB patients. In this review, we discuss the experimental evidence, provided by basic research, regarding micronutrients in the TB field. However, when these studies are applied to clinical trials, the data are inconsistent, indicating that still missing mechanisms are necessary to propose alternatives to the treatment of TB patients.


Assuntos
Desnutrição/complicações , Micronutrientes/imunologia , Tuberculose/etiologia , Países em Desenvolvimento/estatística & dados numéricos , Humanos , Desnutrição/epidemiologia , Desnutrição/prevenção & controle , Micronutrientes/deficiência , Mycobacterium tuberculosis/imunologia , Fatores de Risco , Tuberculose/prevenção & controle
4.
Nutrition ; 70: 110585, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31698296

RESUMO

OBJECTIVES: Micronutrient deficiencies are common among people living with HIV (PLWHIV). The clinical and immunologic consequences of micronutrient deficiencies have been poorly explored in the context of human immunodeficiency virus (HIV) infection. The aim of this study was to determine the prevalence of zinc and selenium deficiency (dietary intake and serum concentrations) and analyze their associations with absolute CD4+ T-cell counts, inflammation markers, and metabolic disorders in a cohort of antiretroviral-experienced HIV-infected individuals. METHODS: The zinc and selenium intakes of 124 HIV-infected men were estimated using 3-d food records. In a subcohort of 45 individuals, serum zinc and selenium concentrations and proinflammatory cytokines were determined. Body composition, bone mineral density (BMD), CD4+ T-cell counts, lipid profile, glucose, and blood pressure were determined and were associated with zinc and selenium dietary intake and serum concentrations. RESULTS: Of the PLWHIV studied, 58% had suboptimal intake of zinc and 8% demonstrated suboptimal intake of selenium. Serum deficiencies for zinc and selenium were 23.9% and 65.9%, respectively. Zinc and selenium intake were correlated with increased muscle mass. Selenium intake was associated with increased BMD of the lumbar region. An inverse correlation between serum selenium concentration and several proinflammatory cytokines (interleukin-1ß, interleukin-6, and tumor necrosis factor-α) was found. CONCLUSION: Suboptimal zinc and selenium intake and serum concentration deficiencies are highly prevalent in treated HIV-positive individuals and are associated with body composition, BMD, and inflammation. Clinical trials should be designed to explore the effect of zinc and selenium supplementation on metabolic, inflammatory, and immunologic parameters on the HIV-positive population.


Assuntos
Dieta/estatística & dados numéricos , Infecções por HIV/complicações , HIV , Selênio/deficiência , Zinco/deficiência , Adulto , Antirretrovirais/uso terapêutico , Contagem de Linfócito CD4 , Citocinas/sangue , Dieta/efeitos adversos , Inquéritos sobre Dietas , Infecções por HIV/sangue , Infecções por HIV/virologia , Humanos , Mediadores da Inflamação/sangue , Masculino , México/epidemiologia , Micronutrientes/análise , Micronutrientes/deficiência , Pessoa de Meia-Idade , Estado Nutricional , Prevalência , Estudos Retrospectivos , Selênio/análise , Zinco/análise
5.
Nutr Hosp ; 32(6): 2898-902, 2015 Dec 01.
Artigo em Espanhol | MEDLINE | ID: mdl-26667750

RESUMO

INTRODUCTION: weight and height measurements are important data for the nutritional assessment of elderly people and the implementation of the nutritional care process. Malnutrition is common in this population, who has high rates of disability that difficult to measurement this variables. OBJECTIVE: evaluate the validity of predictive equations for weight and height that include body circumferences created for brazilian population, in mexican elderly people. METHODS: this is a comparative, observational, prospective and cross-sectional study, 61 elderly were evaluated. Body weight, height, half span, calf, arm and abdominal circumferences were determinated. Weight and height were estimated with de predictive equations published by Rabito et al. Bland-Altman analysis and Intraclass Correlation Coefficient were used to assess the levels of agreement between the estimated and the measured values. The level of statistical significance was p < 0.05. RESULTS: the age mean was 78.7 ± 8.7 and 55.7% were females. The weight mean was 61.9 ± 14.1 kg, height mean was 155.4 ± 9.5 cm and Body Mass Index (BMI) mean corresponded to 25.5 ± 5.1 kg/m. The Bland-Altman plots indicated that the 95% confidence interval (95% IC) limits for the difference between real and estimated weight ranged from -14.3 kg to 8.1 kg, the mean of the difference or systematic error (SE) was -3.1 kg, we observed an statistically significant coefficient of 0.12 (p < 0.03). The 95% IC limits for the difference between real and estimated height ranged from -11.1 to 15.9 cm, the diffe rence mean or SE of 2.4 cm, we observed a coefficient of -0.04 (p = 0.67) . Intraclass Correlation Coefficient of 0.72 (p < 0.00) and 0.88 (p < 0.00) were obtained for weight and height, respectively. CONCLUSION: the equations developed by Rabito showed a good agreement when compared with the actual weight and height of elderly people. We observed variations in the estimated weight in obesity elderlys.


Introducción: el conocimiento del peso y la talla es fundamental en la evaluación del estado nutricional en el adulto mayor, permitiendo la implementación del proceso de cuidado nutricional. La desnutrición es común en este grupo poblacional, el cual usualmente presenta diversas situaciones clínicas que dificultan la medición de peso y talla. Objetivos: evaluar la validez de las ecuaciones para estimar peso y talla basadas en circunferencias corporales propuestas para población brasileña en adultos mayores mexicanos. Métodos: estudio comparativo, observacional, prospectivo y transversal en 61 adultos mayores. Las medidas antropométricas recolectadas fueron peso y talla, Extensión de Media Brazada (EMB), Circunferencia Abdominal (CA), Circunferencia Media de Brazo (CMB) y Circunferencia de Pantorrilla (CP). Se estimó el peso y la talla con las ecuaciones propuestas por Rabito y cols. Se utilizó el método Bland-Altman y el Coeficiente de Correlación Intraclase para evaluar la concordancia entre los valores reales y estimados. Se consideró significancia estadística un valor de p < 0,05. Resultados: la edad promedio de los participantes fue de 78,7 ± 8,7 años. El 55,7% (n = 34) fueron mujeres. La media para el peso fue de 61,9 ± 14,1 kg, para la talla de 155,4 ± 9,5 cm y para el Índice de Masa Corporal (IMC) fue de 25,5 ± 5,1 kg/m2. Mediante el método Bland-Altman los límites de intervalo de concordancia de 95% para la diferencia del peso real y el estimado fueron de -14,3 a 8,1 kg, con una media de la diferencia o error sistemático (ES) de -3,1 cm; se observó un coeficiente de 0,12 que fue estadísticamente significativo (p = 0,03). Para la talla se observa un intervalo de confianza de la diferencia entre la talla real y estimada de -11,1 a 15,9, con una media de la diferencia o ES de 2,4 cm y un coeficiente de -0,04 que no fue significativo (p = 0,67). La concordancia entre el peso real y el estimado, según el coeficiente de correlación intraclase, fue de 0,72 (p < 0,00), en el caso de la talla real, y la estimada fue de 0,88 (p < 0,00). Conclusiones: las ecuaciones propuestas por Rabito muestran una buena concordancia con los valores de peso y talla reales en adultos mayores, observando mayor variación para los valores de peso estimado en población con obesidad.


Assuntos
Algoritmos , Antropometria/métodos , Estatura , Peso Corporal , Idoso , Idoso de 80 Anos ou mais , Índice de Massa Corporal , Estudos Transversais , Feminino , Humanos , Masculino , México , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Estudos Prospectivos , Reprodutibilidade dos Testes , Circunferência da Cintura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA